Caris Life Sciences, Inc. (CAI)

NASDAQ: CAI · Real-Time Price · USD

17.60

+0.29 (1.68%)

At close: Jun 23, 2026, 4:00 PM EDT

17.25

-0.35 (-1.99%)

After-hours: Jun 23, 2026, 7:36 PM EDT

Caris Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 23, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Cap	4,975	7,623	-	-	-
Enterprise Value	4,583	7,201	0	0	0
Last Close Price	17.60	26.98	-	-	-
PS Ratio	5.48	9.39	-	-	-
PB Ratio	8.38	2.44	-	-	-
P/TBV Ratio	1.33	1.45	-	-	-
P/FCF Ratio	40.30	113.95	-	-	-
P/OCF Ratio	33.76	91.67	-	-	-
EV/Sales Ratio	5.05	8.87	-	-	-
EV/EBITDA Ratio	35.53	106.33	-	-	-
EV/EBIT Ratio	42.30	159.63	-	-	-
EV/FCF Ratio	37.12	107.65	-	-	-
Debt / Equity Ratio	0.12	0.12	-1.15	-8.46	0.67
Debt / EBITDA Ratio	144.21	5.60	-	-	-
Debt / FCF Ratio	3.09	5.67	-	-	-
Net Debt / Equity Ratio	-0.14	-0.13	-0.12	-0.02	0.11
Net Debt / EBITDA Ratio	-167.00	-6.22	-1.50	-0.15	0.72
Net Debt / FCF Ratio	-3.58	-6.29	-1.23	-0.14	0.58
Asset Turnover	0.79	1.11	1.09	0.54	0.36
Inventory Turnover	1.96	5.29	5.27	4.52	3.80
Quick Ratio	6.35	7.17	0.94	1.90	3.31
Current Ratio	7.05	7.85	1.30	2.55	3.77
Return on Equity (ROE)	-2.31%	-4.78%	189.92%	-293.83%	-127.28%
Return on Assets (ROA)	-1.58%	6.14%	-67.96%	-56.54%	-44.01%
Return on Invested Capital (ROIC)	-9.15%	23.33%	-135.03%	-143.01%	-124.23%
Return on Capital Employed (ROCE)	-1.78%	7.67%	-103.66%	-71.15%	-54.39%
FCF Yield	2.48%	0.88%	-	-	-
Buyback Yield / Dilution	-543.56%	-371.05%	-1.59%	-104626.10%	-
Total Shareholder Return	-543.56%	-371.05%	-1.59%	-104626.10%	-

SEC Filings: 10-K · 10-Q